New incident report
Incident Report Number: 2016-3601
Registrant Reference Number: 2016KP018
Registrant Name (Full Legal Name no abbreviations): Bayer Inc
Address: 2920 matheson BLVD
City: Mississaugua
Prov / State: ON
Country: Canada
Postal Code: L4W 5R6
Domestic Animal
Country: UNITED STATES
Prov / State: UNKNOWN
Unknown
PMRA Registration No. PMRA Submission No. EPA Registration No. Unknown
Product Name: advantage II - unknown
Liquid
Yes
Units: mL
Site: Animal / Usage sur un animal domestique
Unknown
Other
Cat / Chat
Domestic Longhair/Maine Coon
1
Female
9
17
lbs
Skin
>1 wk <=1 mo / > 1 sem < = 1 mois
Unknown / Inconnu
System
Unknown / Inconnu
Yes
No
Died
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
On an unspecified date in approximately Jul2015 the cat had weight loss, coughing/ wheezing. The cat was examined by a veterinarian and was diagnosed with allergies and asthma. The cat was treated with an unknown steroid and was dewormed with an unknown medication. The owner began using a humidifier in the home. In Jul2015 the fleas continued and the cat was switched to an unspecified flea spray. On an unspecified date in 2015 the cat was gaining back weight. In Jan 2016 the cat was having difficulty breathing. On approximately 13Jan2016 the cat was found dead in the yard. No necropsy was performed. No further information is expected, this case is closed.
Death
Weight loss is neither expected nor in line with the pharmaco-toxicological product profile. Initially as well as later reported respiratory tract disorders are likely consequences of the immune disorders, which are unanticipated as well. Death is inconsistent with pharmaco-toxicological product profile. The product has a wide margin of safety. Rather, persistent breathing difficulties and exposure to the outdoors (yard) are suggestive of other causes (e.g asthma attack) for death. Although time to onset is unknown for initially reported signs, it is exceptionally long (several months) for later reported signs, including death. As product was applied only once at an unknown date lack of efficacy is not evident. Also unknown if correct pipette size was used. Overall, considering the prominent serious sign death, product relation is unlikely.